Events

De-Risking Scientific Innovations

Dr Johnny Habchi, Head of R&D Consulting at the Medicines Discovery Catapult, and Dr Philippa Hart, Strategy Lead at the Medicines Discovery Catapult, will lead a session on the topic below: Early translational projects often stall not because the science is weak, but because the understanding of risk narrative, target, product, patient and pathway,...